![David Sheppard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David William Sheppard is currently Chief Executive Officer at HotHouse Therapeutics Ltd. since 2024 and Director at Revona Bio Ltd. since 2023.
Formerly, Dr. Sheppard was Director at Entact Bio Ltd. from 2019 to 2022.
| Società | Posizione | Inizio |
|---|---|---|
Revona Bio Ltd.
 Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused on development RNA targeted drugs | Direttore/Membro del Consiglio | 05/04/2023 |
| Società | Posizione | Fine |
|---|---|---|
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Develops cancer immune therapy | Direttore/Membro del Consiglio | 09/07/2022 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 2 |
|---|---|
Locki Therapeutics Ltd.
Locki Therapeutics Ltd. BiotechnologyHealth Technology Develops cancer immune therapy | Health Technology |
Revona Bio Ltd.
Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused on development RNA targeted drugs | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
